Delivery Order SPE2DR25D1053-SPE2DR26FT233
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,968.60 to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch, a topical anesthetic commonly used for localized pain relief. The contract, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. This competitively awarded, non-set-aside contract has a ceiling value of $1,222.11 with a firm fixed price structure and an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,986.40 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,289.96 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The contract, issued on June 5, 2025, with an ultimate completion date of June 6, 2025, reflects a firm fixed-price arrangement with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a...
- The Defense Logistics Agency awarded a $2,970.43 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. This firm fixed-price contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $17,477.35 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and was awarded on August 19, 2025. This award utilizes no set-aside designation and represents a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.32 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price delivery order carries a ceiling value of $12,698.20 and will be completed by September 25, 2025. The award utilized competitive procedures with no set-aside designation, demonstrating the contractor's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,490.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,607.99 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT233Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,375.55 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain management. The contract, awarded on October 23, 2025, carries a firm fixed price structure with an ultimate completion date of October 24, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. No set-aside designation was applied to this competitive award. This delivery order represents a task order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial portfolio of federal medical contracts demonstrating its capacity to fulfill diverse medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 10/23/25 |